Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Functional Capacity Evaluation (FCE) Frequently Asked Questions
An FCE is a comprehensive assessment used to determine an individual's physical abilities and limitations. This standardized testing process is typically conducted by a trained healthcare professional, such as a physical therapist or occupational therapist.
Clinical Oversight Reduces Claim Costs by Recommending Discharge Over Added PT
To control escalating therapy costs, a managed care organization implemented a system of regular reviews for additional physical therapy (PT) authorization requests. They sought a clinical partner with PT expertise to provide informed recommendations on whether to discharge patients or approve continued therapy.
Workers' Compensation Pharmacy Legislative and Regulatory End of Year Recap
New regulations, proposed legislation, and notable judicial developments made 2024 a significant year for workers' compensation pharmacy programs. For pharmacy benefit management (PBM) roles, staying on top of these changes is critical for compliance and operational efficiency. Here is a recap of some of the major developments in workers' compensation pharmacy we’re watching as we move into 2025.
Managing the Seismic Shift from Inpatient to Outpatient Physical Medicine Services
Learn how shifting rehabilitative care to outpatient services earlier in recovery impacts physical medicine networks and return-to-work outcomes in our insightful conversation with Kim Radcliffe of Enlyte.
Ask The Pharmacist: Preventing Tetanus in Workers’ Compensation
Tetanus is a serious infectious disease that can result from workplace injuries. Caused by spores of the bacterium Clostridium tetani, tetanus is often associated with rusty nails but these spores are found in many environments, including soil, dust and animal feces. All it takes for infection is a small cut, puncture wound, or scrape—common injuries in many workplaces.
Field Case Manager Delivers Early Full Duty Release
A successful recovery takes collaboration, consistency, and care. Discover how our swift action and focus on compliance helped a heavy equipment operator return to full duty 14 weeks faster than guidelines recommend, saving $12,000+ in indemnity and medical costs.